The interleukin-10/interleukin-10Rα axis in fibroblasts limits large intestinal pathology by suppressing Type I interferon signaling
International Immunology · 2026
DOI: 10.1093/intimm/dxag022 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunology, 2026. Verfasst von Takayoshi Ito und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immune Regulation, Department of Microbiology and Immunology, Graduate School of Medicine, The University of Osaka, Suita, Osaka 565-08…. Hauptthemen laut MEDLINE: Interleukin-10, Fibroblasts, Interleukin-10 Receptor alpha Subunit, Interferon Type I. Die Arbeit nennt 79 Literaturangaben. Gefördert von: CREST, Japan Agency for Medical Research and Development, A Grant-in-Aid for Scientific Research.
Abstract (Originalsprache)
Recent studies identified that the dysregulation of fibroblast activity, in addition to impairment in epithelial integrity and uncontrolled immune response, is implicated in the pathogenesis of inflammatory bowel disease (IBD). The anti-inflammatory cytokine interleukin (IL)-10 and its receptors IL-10Rα and IL-10Rβ have IBD-associated single nucleotide polymorphisms. In the intestine, IL-10 signaling is essential for maintaining an anti-inflammatory state of myeloid cells and inducing regulatory T cells, thereby preventing intestinal inflammation linked to IBD development. However, its impact on the physiology and pathophysiology of intestinal fibroblasts is poorly understood. Here, we show that Il10ra deficiency leads to increased expression of a subset of genes in colonic fibroblasts, most of which are associated with the Type I interferon (IFN) and Type II IFN signaling pathways. In addition, Pdgfra-cre; Il10raf/f mice aged 16 weeks or older develop chronic spontaneous colitis and subsequent fibrosis accompanied by enhanced infiltration by myeloid cells and effector CD4+ T cells in the lamina propria of the colon. Moreover, Pdgfra-cre; Il10raf/f mice at 12 weeks of age exhibit more severe clinical symptoms than those of Il10raf/f mice during dextran sodium sulfate–induced colitis that can be suppressed by the administration of anti-IFNAR1 antibody but not anti-IFNGR1 antibody. Therefore, inhibition of the Type I IFN pathway via IL-10Rα signaling in fibroblasts is one of the IL-10–dependent mechanisms underlying the prevention of large intestinal pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Immune Regulation, Department of Microbiology and Immunology, Graduate School of Medicine, The University of Osaka, Suita, Osaka 565-0871, Japan.
- Department of Gastroenterology, Endoscopy Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200136, China.
- Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, Suita, Osaka 565-0871, Japan.
- WPI Immunology Frontier Research Center, The University of Osaka, Suita, Osaka 565-0871, Japan.
- Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka, Suita 565-0871, Japan.
- Genome Information Research Center, Research Institute for Microbial Diseases, The University of Osaka, Suita, Osaka 565-0871, Japan.
ORCID-Profile: Takayuki Ogino, Daisuke Okuzaki, Kiyoshi Takeda, Hisako Kayama
Förderung
- CREST
- Japan Agency for Medical Research and Development
- A Grant-in-Aid for Scientific Research
- PRIME
- JST
- FOREST
Zitieren
APA
Ito, T., Li, B., Sakaguchi, T., Yagita-Sakamaki, M., Itoi, H., Murakami, M., Wu, R., Fukada, A., Motooka, D., Ogino, T., Nakamura, S., Okuzaki, D., Takeda, K., & Kayama, H. (2026). The interleukin-10/interleukin-10Rα axis in fibroblasts limits large intestinal pathology by suppressing Type I interferon signaling. International Immunology. https://doi.org/10.1093/intimm/dxag022
Vancouver
Ito T, Li B, Sakaguchi T, Yagita-Sakamaki M, Itoi H, Murakami M, et al. The interleukin-10/interleukin-10Rα axis in fibroblasts limits large intestinal pathology by suppressing Type I interferon signaling. International Immunology. 2026. doi:10.1093/intimm/dxag022
BibTeX
@article{Ito2026,
author = {Ito, Takayoshi and Li, Bo and Sakaguchi, Taiki and Yagita-Sakamaki, Mayu and Itoi, Hiroyuki and Murakami, Mari and Wu, Runlin and Fukada, Akio and Motooka, Daisuke and Ogino, Takayuki and Nakamura, Shota and Okuzaki, Daisuke and Takeda, Kiyoshi and Kayama, Hisako},
title = {The interleukin-10/interleukin-10Rα axis in fibroblasts limits large intestinal pathology by suppressing Type I interferon signaling},
journal = {International Immunology},
year = {2026},
doi = {10.1093/intimm/dxag022}
}
EUVIMED